Unknown NA INTERVENTIONAL 2-arm NCT01720459

Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients

Effects of Micronized Trans-resveratrol Treatment on Clinical, Endocrine, Metabolic and Biochemical Parameters of Women With Polycystic Ovary Syndrome: Placebo-controlled Randomized Single-blind Study

Sponsor: Poznan University of Medical Sciences

Conditions Polycystic Ovary Syndrome (PCOS)

Interventions Micronized trans-resveratrol Placebo

Updated 5 times since 2017 Last updated: Nov 1, 2012 Started: Dec 31, 2012 Primary completion: Dec 31, 2013 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Polycystic Ovary Syndrome (PCOS), this trial is ongoing. The trial is conducted by Poznan University of Medical Sciences and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Poznan University of Medical Sciences
University of California, Davis

Data source: Poznan University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Poznan, Poland